日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese clinical trial shows breakthrough in liver cancer survival

By ZHOU WENTING in Shanghai | chinadaily.com.cn | Updated: 2026-03-05 21:29
Share
Share - WeChat
Doctors from Shanghai-based Zhongshan Hospital, affiliated with Fudan University, brief the media on Thursday on the results of a multicenter clinical study showing that an innovative neoadjuvant treatment for intrahepatic cholangiocarcinoma, a common malignant liver tumor, can significantly extend patient survival. [Photo provided to chinadaily.com.cn]

A pioneering Chinese study has found that a new drug cocktail administered before surgery can nearly double the time patients with a deadly form of liver cancer live without the disease returning.

The study, published Thursday in the New England Journal of Medicine, focused on intrahepatic cholangiocarcinoma, or ICC. This cancer forms in the bile ducts inside the liver and is notorious for being "silent," often discovered only after it has reached an advanced stage.

Led by Zhongshan Hospital, affiliated with Fudan University, the trial involved 11 hospitals across China. Experts say the findings offer a new "standard of care" for a disease where the five-year survival rate after surgery is currently only 25 percent to 40 percent.

The researchers tested a neoadjuvant protocol, which is a treatment given as a first step to shrink a tumor before the main surgery. In this trial, 178 patients with a median age of 59 were recruited by February 2024. One group received three cycles of Gemox chemotherapy along with a targeted therapy drug and an immunotherapy drug, which helps the body's own immune system recognize and attack cancer cells. The other group underwent immediate surgery, which is the traditional standard practice.

The results showed that the drug combination significantly delayed the return of the cancer. The median event-free survival — the length of time after treatment that a patient remains free of specific complications or cancer recurrence — was 18 months for those who received the drug cocktail. In contrast, the group that went straight to surgery saw a median of only 8.7 months.

Shi Guoming, one of the lead researchers, noted that the tumors in the drug-treatment group significantly shrank, with an objective response rate of 55 percent. This term refers to the percentage of patients whose tumors partially or completely disappeared during the treatment phase.

China is disproportionately affected by this disease, seeing over 50,000 new cases annually, which accounts for more than half of the global total. The study, which began in 2021, also showed a promising trend in overall survival. The 24-month survival rate for the drug-protocol group was 79 percent, compared to 61 percent for the surgery-only group.

Zhou Jian, president of Zhongshan Hospital, said that as the study progresses, it may further demonstrate long-term benefits for patients. The team presented preliminary results at the annual meeting of the European Society for Medical Oncology in Germany in October 2024, where it garnered international attention. Shi expressed hope that the findings will be further validated through international studies so the Chinese protocol can eventually be used as a global cure.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 秋霞成人午夜鲁丝一区二区三区 | 成人免费看片视频在线观看 | 成人免费视频入口 | 精品一区二区在线视频 | 在线视频久 | 一区二区视频免费在线观看 | 国产香蕉9 | 久久在线视频 | 天堂网中文字幕 | a国产视频 | 91高清在线视频 | 亚洲精品一区二区三区蜜桃 | 天天色天天射天天干 | 国产精品爽爽爽 | 狼性av懂色av禁果av | 人人草网 | 日韩在线精品视频 | 91国产视频在线观看 | 樱桃视频污在线观看 | 久操av在线| 在线播放中文字幕 | 成人欧美一区 | 亚洲色图网站 | 亚洲免费专区 | 日本视频免费在线 | 日本二区三区视频 | 91超碰人人 | 翔田千里在线视频 | 久久天天综合 | 日韩中文字幕视频 | 男人的天堂av网站 | 欧美在线日韩在线 | 美日韩在线观看 | 8x8ⅹ国产精品一区二区 | 91在线一区二区三区 | 欧美成人手机在线 | 婷婷久| 中文亚洲欧美 | 九九热最新地址 | 中文字幕在线视频播放 | 激情久久婷婷 |